BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Diagnosis
56 results:

  • 1. Sociocultural factors associated with physical activity in Black prostate cancer survivors.
    Buro AW; Carson TL; Small BJ; Fan W; Oswald LB; Jim HSL; Salas E; Zambrano K; Bryant C; Yamoah K; Gwede CK; Park JY; Gonzalez BD
    Support Care Cancer; 2023 Jul; 31(8):482. PubMed ID: 37479918
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.
    Yonese J; Hinata N; Masui S; Nakai Y; Shirotake S; Takeuchi A; Inamoto T; Nozawa M; Ueda K; Etsunaga T; Osawa T; Uemura M; Kimura G; Numakura K; Yamana K; Miyake H; Fukasawa S; Morishima N; Ito H; Uemura H
    Int J Urol; 2023 Sep; 30(9):762-771. PubMed ID: 37248753
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Use of expectant management based on prostate cancer risk and health status: How far are we from a risk-adapted approach?
    Spratte BN; Tan HJ; Zambrano IA; Basak RS; Filson CP; Jacobs BL; Hwang S
    Urol Oncol; 2023 Jul; 41(7):323.e17-323.e25. PubMed ID: 37149430
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Impact of Sarcopenia Onset Prior to cancer diagnosis on cancer Survival: A National Population-Based Cohort Study Using Propensity Score Matching.
    Su CH; Chen WM; Chen MC; Shia BC; Wu SY
    Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904245
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Incremental Health Care Costs of Anxiety and Depression Among Medicare Beneficiaries With cancer.
    Birch K; Chung S; Zion SR; MacEwan JP; Malecki MJ
    JCO Oncol Pract; 2023 May; 19(5):e660-e671. PubMed ID: 36800552
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effectiveness and Accuracy of MRI-Ultrasound Fusion Targeted Biopsy Based on PI-RADS v2.1 Category in Transition/Peripheral Zone of the prostate.
    Liu Y; Wang S; Xu G; Zhou B; Zhang Y; Ye B; Xiang L; Zhang Y; Xu H
    J Magn Reson Imaging; 2023 Sep; 58(3):709-717. PubMed ID: 36773016
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparison of skeletal segmentation by deep learning-based and atlas-based segmentation in prostate cancer patients.
    Motegi K; Miyaji N; Yamashita K; Koizumi M; Terauchi T
    Ann Nucl Med; 2022 Sep; 36(9):834-841. PubMed ID: 35773557
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genomic Features of Lung-Recurrent Hormone-Sensitive prostate cancer.
    Fonseca NM; Van der Eecken K; Herberts C; Verbeke S; Ng SWS; Lumen N; Ritch E; Murtha AJ; Bernales CQ; Schönlau E; Moris L; Van Dorpe J; Annala M; Wyatt AW; Ost P
    JCO Precis Oncol; 2022 Apr; 6():e2100543. PubMed ID: 35507889
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
    Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
    [No Abstract]    [Full Text] [Related]  

  • 10. [MRI/TRUS cognitive fusion combined with 12-core systematic transperineal prostate biopsy for the diagnosis of clinically significant prostate cancer: A report of 208 cases].
    Fu ZY; Sun LG; Zhang G; Gu YF; Bei ML; Hu J; Chen YC; Zhang J
    Zhonghua Nan Ke Xue; 2021 May; 27(5):421-425. PubMed ID: 34914317
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of Novel diagnosis Biomarkers for Therapy-Related Neuroendocrine prostate cancer.
    Zhang C; Qian J; Wu Y; Zhu Z; Yu W; Gong Y; Li X; He Z; Zhou L
    Pathol Oncol Res; 2021; 27():1609968. PubMed ID: 34646089
    [No Abstract]    [Full Text] [Related]  

  • 12. Adherence to Mediterranean Diet, Physical Activity and Survival after prostate cancer diagnosis.
    Di Maso M; Augustin LSA; Toffolutti F; Stocco C; Dal Maso L; Jenkins DJA; Fleshner NE; Serraino D; Polesel J
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33467042
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Performance of Three Inherited Risk Measures for Predicting prostate cancer Incidence and Mortality: A Population-based Prospective Analysis.
    Shi Z; Platz EA; Wei J; Na R; Fantus RJ; Wang CH; Eggener SE; Hulick PJ; Duggan D; Zheng SL; Cooney KA; Isaacs WB; Helfand BT; Xu J
    Eur Urol; 2021 Mar; 79(3):419-426. PubMed ID: 33257031
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Posttraumatic stress disorder and suicide among veterans with prostate cancer.
    Aboumrad M; Shiner B; Mucci L; Neupane N; Schroeck FR; Klaassen Z; Freedland SJ; Young-Xu Y
    Psychooncology; 2021 Apr; 30(4):581-590. PubMed ID: 33247977
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Did quality of life for older cancer survivors improve with the turn of the century in the United States?
    Mahal AR; Cramer LD; Wang EH; Wang S; Davidoff AJ; Gross CP; Yu JB
    J Geriatr Oncol; 2021 Jan; 12(1):102-105. PubMed ID: 32535014
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MRI-Targeted, Systematic, and Combined Biopsy for prostate cancer diagnosis.
    Ahdoot M; Wilbur AR; Reese SE; Lebastchi AH; Mehralivand S; Gomella PT; Bloom J; Gurram S; Siddiqui M; Pinsky P; Parnes H; Linehan WM; Merino M; Choyke PL; Shih JH; Turkbey B; Wood BJ; Pinto PA
    N Engl J Med; 2020 Mar; 382(10):917-928. PubMed ID: 32130814
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Long Noncoding RNA
    Xie M; Zhang Z; Cui Y
    Cancer Biother Radiopharm; 2020 Mar; 35(2):109-119. PubMed ID: 32077748
    [No Abstract]    [Full Text] [Related]  

  • 18. Syncope as a sign of occult cancers: a population-based cohort study.
    Lorenzen MOB; Farkas DK; Adelborg K; Sundbøll J; Sørensen HT
    Br J Cancer; 2020 Feb; 122(4):595-600. PubMed ID: 31857722
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy.
    Narita S; Nomura K; Hatakeyama S; Takahashi M; Sakurai T; Kawamura S; Hoshi S; Ishida M; Kawaguchi T; Ishidoya S; Shimoda J; Sato H; Mitsuzuka K; Tochigi T; Tsuchiya N; Ohyama C; Arai Y; Nagashima K; Habuchi T
    Cancer Med; 2019 Nov; 8(15):6566-6577. PubMed ID: 31508900
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospital.
    Donato P; Morton A; Yaxley J; Teloken PE; Coughlin G; Esler R; Dunglison N; Gardiner RA; Roberts MJ
    World J Urol; 2020 Feb; 38(2):371-379. PubMed ID: 31055625
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.